1. St. Paul’s Hospital, University of British Columbia, Vancouver, Canada;
2. Service of Hematology, Centre Hospitalier Métropole Savoie, Chambery, France;
3. Clinical Hematology, Avignon Hospital, Avignon, France;
4. Department of Hematology, AZ St. Jan AV, Brugge, Belgium;
5. Service Hématologie, Hôpital Belle Isle, HP Metz, France;
6. OCA Hospital, Monterrey, México;
7. Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, Canada;
8. Hospital da Luz, Lisbon, Portugal;
9. Centre Hospitalier Universitaire, Nancy, France;
10. Centre d’Investigations Cliniques, AP-HP, Hôpital Saint-Louis, Université Paris Diderot, INSERM CIC 1427, Paris, France;
11. Novartis AG, Basel, Switzerland;
12. Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA;
13. Department of Hematology, University Hospitals Leuven, Leuven, Belgium;
14. Laboratory of Experimental Transplantation, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium